Kennett Square, United States
Mirador Global LLC is a consulting firm recently acquired by Citrus Health Group that specializes in providing drug commercialization assessment and launch planning services within the pharmaceutical industry. Founded in 2016, their primary focus is on Oncology, Immuno-Oncology, Orphan and CNS/Pain/Addiction for small and medium-sized bio-pharma companies globally. Their expertise in strategic planning, marketing, market access, pricing, medical affairs, and analytics sets them apart in the industry.
What sets Mirador Global apart is their proprietary Integration Methodology, addressing the crucial gap in successfully creating and executing product launches. Their services include global commercial strategy development, US & Global forecasting and asset valuation, payer reimbursement risk assessment & mitigation, portfolio assessment and prioritization, and commercial road map and launch planning.
With a team that has sat in the seats of their clients for decades, Mirador Global offers unique insights and support, providing selective assistance to commercial teams or serving as initial commercial teams for companies before they are ready to internally hire. Their focus on professional therapeutic experience and personal passion contributes to their exceptional level of work.
Overall, Mirador Global LLC presents an intriguing investment opportunity, given its unique positioning in the pharmaceutical industry and its recent acquisition by Citrus Health Group.
